Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 7 |
NetGPI | no | yes: 0, no: 7 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A4IB86
Term | Name | Level | Count |
---|---|---|---|
GO:0006468 | protein phosphorylation | 5 | 8 |
GO:0006793 | phosphorus metabolic process | 3 | 8 |
GO:0006796 | phosphate-containing compound metabolic process | 4 | 8 |
GO:0006807 | nitrogen compound metabolic process | 2 | 8 |
GO:0008152 | metabolic process | 1 | 8 |
GO:0009987 | cellular process | 1 | 8 |
GO:0016310 | phosphorylation | 5 | 8 |
GO:0019538 | protein metabolic process | 3 | 8 |
GO:0036211 | protein modification process | 4 | 8 |
GO:0043170 | macromolecule metabolic process | 3 | 8 |
GO:0043412 | macromolecule modification | 4 | 8 |
GO:0044237 | cellular metabolic process | 2 | 8 |
GO:0044238 | primary metabolic process | 2 | 8 |
GO:0071704 | organic substance metabolic process | 2 | 8 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 8 |
GO:0018105 | peptidyl-serine phosphorylation | 6 | 1 |
GO:0018107 | peptidyl-threonine phosphorylation | 6 | 1 |
GO:0018193 | peptidyl-amino acid modification | 5 | 1 |
GO:0018209 | peptidyl-serine modification | 6 | 1 |
GO:0018210 | peptidyl-threonine modification | 6 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0000166 | nucleotide binding | 3 | 8 |
GO:0003824 | catalytic activity | 1 | 8 |
GO:0004672 | protein kinase activity | 3 | 8 |
GO:0005488 | binding | 1 | 8 |
GO:0005524 | ATP binding | 5 | 8 |
GO:0016301 | kinase activity | 4 | 8 |
GO:0016740 | transferase activity | 2 | 8 |
GO:0016772 | transferase activity, transferring phosphorus-containing groups | 3 | 8 |
GO:0016773 | phosphotransferase activity, alcohol group as acceptor | 4 | 8 |
GO:0017076 | purine nucleotide binding | 4 | 8 |
GO:0030554 | adenyl nucleotide binding | 5 | 8 |
GO:0032553 | ribonucleotide binding | 3 | 8 |
GO:0032555 | purine ribonucleotide binding | 4 | 8 |
GO:0032559 | adenyl ribonucleotide binding | 5 | 8 |
GO:0035639 | purine ribonucleoside triphosphate binding | 4 | 8 |
GO:0036094 | small molecule binding | 2 | 8 |
GO:0043167 | ion binding | 2 | 8 |
GO:0043168 | anion binding | 3 | 8 |
GO:0097159 | organic cyclic compound binding | 2 | 8 |
GO:0097367 | carbohydrate derivative binding | 2 | 8 |
GO:0140096 | catalytic activity, acting on a protein | 2 | 8 |
GO:1901265 | nucleoside phosphate binding | 3 | 8 |
GO:1901363 | heterocyclic compound binding | 2 | 8 |
GO:0004674 | protein serine/threonine kinase activity | 4 | 1 |
GO:0004713 | protein tyrosine kinase activity | 4 | 1 |
GO:0004712 | protein serine/threonine/tyrosine kinase activity | 4 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 219 | 223 | PF00656 | 0.508 |
CLV_C14_Caspase3-7 | 566 | 570 | PF00656 | 0.731 |
CLV_NRD_NRD_1 | 25 | 27 | PF00675 | 0.662 |
CLV_NRD_NRD_1 | 314 | 316 | PF00675 | 0.466 |
CLV_NRD_NRD_1 | 379 | 381 | PF00675 | 0.465 |
CLV_NRD_NRD_1 | 481 | 483 | PF00675 | 0.347 |
CLV_PCSK_KEX2_1 | 379 | 381 | PF00082 | 0.441 |
CLV_PCSK_KEX2_1 | 481 | 483 | PF00082 | 0.401 |
CLV_PCSK_KEX2_1 | 499 | 501 | PF00082 | 0.192 |
CLV_PCSK_PC1ET2_1 | 499 | 501 | PF00082 | 0.401 |
CLV_PCSK_SKI1_1 | 184 | 188 | PF00082 | 0.589 |
CLV_PCSK_SKI1_1 | 272 | 276 | PF00082 | 0.328 |
CLV_PCSK_SKI1_1 | 408 | 412 | PF00082 | 0.401 |
CLV_PCSK_SKI1_1 | 511 | 515 | PF00082 | 0.393 |
DEG_APCC_DBOX_1 | 194 | 202 | PF00400 | 0.310 |
DEG_SCF_FBW7_1 | 146 | 151 | PF00400 | 0.786 |
DOC_CKS1_1 | 162 | 167 | PF01111 | 0.695 |
DOC_CYCLIN_RxL_1 | 528 | 536 | PF00134 | 0.418 |
DOC_MAPK_DCC_7 | 195 | 203 | PF00069 | 0.518 |
DOC_MAPK_gen_1 | 26 | 32 | PF00069 | 0.650 |
DOC_MAPK_gen_1 | 264 | 273 | PF00069 | 0.351 |
DOC_MAPK_gen_1 | 315 | 322 | PF00069 | 0.487 |
DOC_MAPK_gen_1 | 417 | 426 | PF00069 | 0.347 |
DOC_MAPK_gen_1 | 508 | 516 | PF00069 | 0.393 |
DOC_MAPK_HePTP_8 | 261 | 273 | PF00069 | 0.401 |
DOC_MAPK_HePTP_8 | 414 | 426 | PF00069 | 0.347 |
DOC_MAPK_MEF2A_6 | 195 | 203 | PF00069 | 0.518 |
DOC_MAPK_MEF2A_6 | 264 | 273 | PF00069 | 0.314 |
DOC_MAPK_MEF2A_6 | 417 | 426 | PF00069 | 0.347 |
DOC_PP1_RVXF_1 | 394 | 401 | PF00149 | 0.347 |
DOC_PP2B_LxvP_1 | 426 | 429 | PF13499 | 0.347 |
DOC_USP7_MATH_1 | 454 | 458 | PF00917 | 0.324 |
DOC_USP7_MATH_1 | 48 | 52 | PF00917 | 0.662 |
DOC_USP7_MATH_1 | 5 | 9 | PF00917 | 0.644 |
DOC_USP7_MATH_1 | 67 | 71 | PF00917 | 0.726 |
DOC_WW_Pin1_4 | 144 | 149 | PF00397 | 0.726 |
DOC_WW_Pin1_4 | 161 | 166 | PF00397 | 0.523 |
DOC_WW_Pin1_4 | 174 | 179 | PF00397 | 0.574 |
DOC_WW_Pin1_4 | 539 | 544 | PF00397 | 0.347 |
LIG_14-3-3_CanoR_1 | 107 | 114 | PF00244 | 0.691 |
LIG_14-3-3_CanoR_1 | 184 | 190 | PF00244 | 0.429 |
LIG_14-3-3_CanoR_1 | 339 | 347 | PF00244 | 0.407 |
LIG_14-3-3_CanoR_1 | 408 | 414 | PF00244 | 0.401 |
LIG_BRCT_BRCA1_1 | 181 | 185 | PF00533 | 0.652 |
LIG_BRCT_BRCA1_1 | 199 | 203 | PF00533 | 0.578 |
LIG_BRCT_BRCA1_1 | 310 | 314 | PF00533 | 0.401 |
LIG_BRCT_BRCA1_1 | 341 | 345 | PF00533 | 0.401 |
LIG_BRCT_BRCA1_1 | 389 | 393 | PF00533 | 0.442 |
LIG_BRCT_BRCA1_2 | 310 | 316 | PF00533 | 0.418 |
LIG_CtBP_PxDLS_1 | 180 | 184 | PF00389 | 0.668 |
LIG_deltaCOP1_diTrp_1 | 435 | 439 | PF00928 | 0.401 |
LIG_deltaCOP1_diTrp_1 | 548 | 555 | PF00928 | 0.401 |
LIG_FHA_1 | 145 | 151 | PF00498 | 0.782 |
LIG_FHA_1 | 162 | 168 | PF00498 | 0.538 |
LIG_FHA_1 | 251 | 257 | PF00498 | 0.376 |
LIG_FHA_1 | 288 | 294 | PF00498 | 0.401 |
LIG_FHA_1 | 353 | 359 | PF00498 | 0.363 |
LIG_FHA_1 | 429 | 435 | PF00498 | 0.347 |
LIG_FHA_1 | 55 | 61 | PF00498 | 0.763 |
LIG_FHA_1 | 562 | 568 | PF00498 | 0.713 |
LIG_FHA_2 | 115 | 121 | PF00498 | 0.656 |
LIG_FHA_2 | 185 | 191 | PF00498 | 0.559 |
LIG_FHA_2 | 430 | 436 | PF00498 | 0.401 |
LIG_LIR_Apic_2 | 416 | 422 | PF02991 | 0.347 |
LIG_LIR_Apic_2 | 78 | 84 | PF02991 | 0.774 |
LIG_LIR_Gen_1 | 327 | 338 | PF02991 | 0.401 |
LIG_LIR_Gen_1 | 522 | 533 | PF02991 | 0.385 |
LIG_LIR_Nem_3 | 103 | 109 | PF02991 | 0.729 |
LIG_LIR_Nem_3 | 117 | 121 | PF02991 | 0.695 |
LIG_LIR_Nem_3 | 171 | 176 | PF02991 | 0.751 |
LIG_LIR_Nem_3 | 253 | 257 | PF02991 | 0.347 |
LIG_LIR_Nem_3 | 327 | 333 | PF02991 | 0.401 |
LIG_LIR_Nem_3 | 438 | 442 | PF02991 | 0.401 |
LIG_LIR_Nem_3 | 467 | 472 | PF02991 | 0.349 |
LIG_LIR_Nem_3 | 522 | 528 | PF02991 | 0.385 |
LIG_LIR_Nem_3 | 548 | 554 | PF02991 | 0.401 |
LIG_MAD2 | 364 | 372 | PF02301 | 0.389 |
LIG_MLH1_MIPbox_1 | 199 | 203 | PF16413 | 0.578 |
LIG_MYND_1 | 148 | 152 | PF01753 | 0.703 |
LIG_SH2_CRK | 106 | 110 | PF00017 | 0.720 |
LIG_SH2_CRK | 173 | 177 | PF00017 | 0.638 |
LIG_SH2_CRK | 231 | 235 | PF00017 | 0.396 |
LIG_SH2_CRK | 330 | 334 | PF00017 | 0.401 |
LIG_SH2_CRK | 81 | 85 | PF00017 | 0.694 |
LIG_SH2_NCK_1 | 330 | 334 | PF00017 | 0.401 |
LIG_SH2_NCK_1 | 81 | 85 | PF00017 | 0.682 |
LIG_SH2_PTP2 | 318 | 321 | PF00017 | 0.468 |
LIG_SH2_SRC | 197 | 200 | PF00017 | 0.564 |
LIG_SH2_SRC | 330 | 333 | PF00017 | 0.468 |
LIG_SH2_STAP1 | 280 | 284 | PF00017 | 0.347 |
LIG_SH2_STAP1 | 430 | 434 | PF00017 | 0.347 |
LIG_SH2_STAT3 | 280 | 283 | PF00017 | 0.401 |
LIG_SH2_STAT3 | 475 | 478 | PF00017 | 0.293 |
LIG_SH2_STAT5 | 173 | 176 | PF00017 | 0.725 |
LIG_SH2_STAT5 | 197 | 200 | PF00017 | 0.573 |
LIG_SH2_STAT5 | 202 | 205 | PF00017 | 0.428 |
LIG_SH2_STAT5 | 280 | 283 | PF00017 | 0.401 |
LIG_SH2_STAT5 | 318 | 321 | PF00017 | 0.401 |
LIG_SH2_STAT5 | 413 | 416 | PF00017 | 0.351 |
LIG_SH2_STAT5 | 430 | 433 | PF00017 | 0.380 |
LIG_SH2_STAT5 | 468 | 471 | PF00017 | 0.347 |
LIG_SH2_STAT5 | 475 | 478 | PF00017 | 0.347 |
LIG_SH3_1 | 499 | 505 | PF00018 | 0.404 |
LIG_SH3_1 | 81 | 87 | PF00018 | 0.765 |
LIG_SH3_3 | 159 | 165 | PF00018 | 0.703 |
LIG_SH3_3 | 175 | 181 | PF00018 | 0.659 |
LIG_SH3_3 | 448 | 454 | PF00018 | 0.347 |
LIG_SH3_3 | 499 | 505 | PF00018 | 0.373 |
LIG_SH3_3 | 61 | 67 | PF00018 | 0.773 |
LIG_SH3_3 | 81 | 87 | PF00018 | 0.440 |
LIG_SUMO_SIM_anti_2 | 290 | 295 | PF11976 | 0.444 |
LIG_TRAF2_1 | 188 | 191 | PF00917 | 0.465 |
LIG_TRAF2_1 | 284 | 287 | PF00917 | 0.401 |
LIG_TRAF2_1 | 403 | 406 | PF00917 | 0.401 |
LIG_TRFH_1 | 322 | 326 | PF08558 | 0.401 |
LIG_WRC_WIRS_1 | 436 | 441 | PF05994 | 0.401 |
MOD_CK1_1 | 12 | 18 | PF00069 | 0.603 |
MOD_CK1_1 | 151 | 157 | PF00069 | 0.725 |
MOD_CK1_1 | 391 | 397 | PF00069 | 0.424 |
MOD_CK1_1 | 560 | 566 | PF00069 | 0.640 |
MOD_CK2_1 | 114 | 120 | PF00069 | 0.654 |
MOD_CK2_1 | 184 | 190 | PF00069 | 0.522 |
MOD_CK2_1 | 383 | 389 | PF00069 | 0.374 |
MOD_CK2_1 | 399 | 405 | PF00069 | 0.348 |
MOD_CK2_1 | 454 | 460 | PF00069 | 0.324 |
MOD_Cter_Amidation | 479 | 482 | PF01082 | 0.389 |
MOD_Cter_Amidation | 496 | 499 | PF01082 | 0.389 |
MOD_GlcNHglycan | 102 | 105 | PF01048 | 0.740 |
MOD_GlcNHglycan | 109 | 112 | PF01048 | 0.706 |
MOD_GlcNHglycan | 14 | 17 | PF01048 | 0.600 |
MOD_GlcNHglycan | 401 | 404 | PF01048 | 0.390 |
MOD_GlcNHglycan | 50 | 53 | PF01048 | 0.764 |
MOD_GlcNHglycan | 69 | 72 | PF01048 | 0.597 |
MOD_GlcNHglycan | 7 | 10 | PF01048 | 0.669 |
MOD_GSK3_1 | 142 | 149 | PF00069 | 0.744 |
MOD_GSK3_1 | 17 | 24 | PF00069 | 0.607 |
MOD_GSK3_1 | 383 | 390 | PF00069 | 0.421 |
MOD_GSK3_1 | 409 | 416 | PF00069 | 0.347 |
MOD_GSK3_1 | 48 | 55 | PF00069 | 0.696 |
MOD_GSK3_1 | 5 | 12 | PF00069 | 0.760 |
MOD_GSK3_1 | 556 | 563 | PF00069 | 0.642 |
MOD_GSK3_1 | 565 | 572 | PF00069 | 0.587 |
MOD_GSK3_1 | 62 | 69 | PF00069 | 0.792 |
MOD_GSK3_1 | 75 | 82 | PF00069 | 0.658 |
MOD_N-GLC_1 | 17 | 22 | PF02516 | 0.660 |
MOD_N-GLC_1 | 278 | 283 | PF02516 | 0.401 |
MOD_N-GLC_1 | 36 | 41 | PF02516 | 0.678 |
MOD_N-GLC_1 | 5 | 10 | PF02516 | 0.666 |
MOD_N-GLC_2 | 158 | 160 | PF02516 | 0.716 |
MOD_NEK2_1 | 308 | 313 | PF00069 | 0.401 |
MOD_NEK2_1 | 567 | 572 | PF00069 | 0.731 |
MOD_PIKK_1 | 54 | 60 | PF00454 | 0.701 |
MOD_PKA_2 | 114 | 120 | PF00069 | 0.654 |
MOD_PKA_2 | 215 | 221 | PF00069 | 0.540 |
MOD_PKA_2 | 555 | 561 | PF00069 | 0.619 |
MOD_Plk_1 | 36 | 42 | PF00069 | 0.679 |
MOD_Plk_1 | 391 | 397 | PF00069 | 0.401 |
MOD_Plk_2-3 | 287 | 293 | PF00069 | 0.468 |
MOD_Plk_4 | 197 | 203 | PF00069 | 0.579 |
MOD_Plk_4 | 471 | 477 | PF00069 | 0.386 |
MOD_ProDKin_1 | 144 | 150 | PF00069 | 0.725 |
MOD_ProDKin_1 | 161 | 167 | PF00069 | 0.522 |
MOD_ProDKin_1 | 174 | 180 | PF00069 | 0.567 |
MOD_ProDKin_1 | 539 | 545 | PF00069 | 0.347 |
MOD_SUMO_for_1 | 370 | 373 | PF00179 | 0.347 |
MOD_SUMO_rev_2 | 131 | 140 | PF00179 | 0.669 |
MOD_SUMO_rev_2 | 286 | 291 | PF00179 | 0.382 |
TRG_DiLeu_BaEn_4 | 286 | 292 | PF01217 | 0.401 |
TRG_DiLeu_BaLyEn_6 | 304 | 309 | PF01217 | 0.468 |
TRG_ENDOCYTIC_2 | 106 | 109 | PF00928 | 0.742 |
TRG_ENDOCYTIC_2 | 118 | 121 | PF00928 | 0.718 |
TRG_ENDOCYTIC_2 | 173 | 176 | PF00928 | 0.641 |
TRG_ENDOCYTIC_2 | 231 | 234 | PF00928 | 0.390 |
TRG_ENDOCYTIC_2 | 243 | 246 | PF00928 | 0.271 |
TRG_ENDOCYTIC_2 | 318 | 321 | PF00928 | 0.385 |
TRG_ENDOCYTIC_2 | 330 | 333 | PF00928 | 0.401 |
TRG_ENDOCYTIC_2 | 450 | 453 | PF00928 | 0.347 |
TRG_ER_diArg_1 | 538 | 541 | PF00400 | 0.468 |
TRG_NLS_Bipartite_1 | 481 | 502 | PF00514 | 0.401 |
TRG_NLS_MonoExtC_3 | 497 | 502 | PF00514 | 0.401 |
TRG_Pf-PMV_PEXEL_1 | 119 | 123 | PF00026 | 0.704 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P4D6 | Leptomonas seymouri | 59% | 80% |
A0A0S4IIU2 | Bodo saltans | 38% | 100% |
A0A0S4IL53 | Bodo saltans | 25% | 85% |
A0A0S4IUF2 | Bodo saltans | 41% | 100% |
A0A1X0NNI0 | Trypanosomatidae | 27% | 73% |
A0A3Q8IB74 | Leishmania donovani | 27% | 100% |
A0A3Q8IC55 | Leishmania donovani | 29% | 100% |
A0A3Q8ITZ9 | Leishmania donovani | 29% | 100% |
A0A3Q8IVR8 | Leishmania donovani | 33% | 100% |
A0A3S5H6C8 | Leishmania donovani | 28% | 100% |
A0A3S5H7N7 | Leishmania donovani | 27% | 100% |
A0A3S7WQK7 | Leishmania donovani | 28% | 100% |
A0A3S7WR45 | Leishmania donovani | 25% | 100% |
A0A3S7WRG1 | Leishmania donovani | 26% | 100% |
A0A3S7WY10 | Leishmania donovani | 24% | 100% |
A0A3S7X2Z6 | Leishmania donovani | 24% | 100% |
A0A3S7X9D1 | Leishmania donovani | 99% | 100% |
A0A3S7XA45 | Leishmania donovani | 30% | 100% |
A4H5L7 | Leishmania braziliensis | 27% | 100% |
A4H641 | Leishmania braziliensis | 24% | 100% |
A4H7F4 | Leishmania braziliensis | 25% | 100% |
A4H9X5 | Leishmania braziliensis | 28% | 100% |
A4HC27 | Leishmania braziliensis | 31% | 100% |
A4HIM5 | Leishmania braziliensis | 28% | 100% |
A4HLJ9 | Leishmania braziliensis | 28% | 100% |
A4HMK7 | Leishmania braziliensis | 83% | 100% |
A4HNG3 | Leishmania braziliensis | 30% | 100% |
A4HNT2 | Leishmania braziliensis | 33% | 100% |
A4HTV4 | Leishmania infantum | 28% | 100% |
A4HTV5 | Leishmania infantum | 28% | 100% |
A4HUG1 | Leishmania infantum | 25% | 100% |
A4HUS3 | Leishmania infantum | 26% | 100% |
A4HZH0 | Leishmania infantum | 29% | 100% |
A4I564 | Leishmania infantum | 24% | 100% |
A4I5X0 | Leishmania infantum | 27% | 100% |
A4IC54 | Leishmania infantum | 30% | 100% |
A4ICR2 | Leishmania infantum | 33% | 100% |
A8WJR8 | Caenorhabditis briggsae | 39% | 71% |
C9ZSU2 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 23% | 90% |
C9ZSX0 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 27% | 74% |
E8NHK0 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 28% | 100% |
E9AF07 | Leishmania major | 94% | 100% |
E9AFX4 | Leishmania major | 30% | 100% |
E9AGS0 | Leishmania infantum | 27% | 100% |
E9AH34 | Leishmania infantum | 23% | 100% |
E9AMP2 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 28% | 100% |
E9AN59 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 25% | 100% |
E9ANF7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 26% | 100% |
E9ARW9 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 27% | 100% |
E9ASJ2 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 33% | 100% |
E9AVG0 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 29% | 100% |
E9AWL2 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 23% | 100% |
E9B164 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 27% | 100% |
E9B3X5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 29% | 100% |
E9B663 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 92% | 100% |
E9B727 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 31% | 100% |
O43781 | Homo sapiens | 38% | 98% |
P83102 | Drosophila melanogaster | 38% | 69% |
Q09815 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 36% | 69% |
Q45FA5 | Physarum polycephalum | 28% | 100% |
Q4Q204 | Leishmania major | 33% | 100% |
Q4Q449 | Leishmania major | 29% | 100% |
Q4Q701 | Leishmania major | 27% | 100% |
Q4QC19 | Leishmania major | 30% | 100% |
Q4QDK3 | Leishmania major | 27% | 100% |
Q4QFG6 | Leishmania major | 35% | 100% |
Q4QH69 | Leishmania major | 26% | 100% |
Q4QHG6 | Leishmania major | 25% | 100% |
Q4QHY3 | Leishmania major | 28% | 100% |
Q4QHY4 | Leishmania major | 28% | 100% |
Q4R6S5 | Macaca fascicularis | 40% | 100% |
Q4V8A3 | Rattus norvegicus | 38% | 98% |
Q5U4C9 | Mus musculus | 41% | 96% |
Q5ZIU3 | Gallus gallus | 40% | 100% |
Q8BI55 | Mus musculus | 37% | 91% |
Q922Y0 | Mus musculus | 38% | 98% |
Q92630 | Homo sapiens | 40% | 96% |
Q9NR20 | Homo sapiens | 38% | 100% |
Q9V3D5 | Drosophila melanogaster | 38% | 80% |
Q9XTF3 | Caenorhabditis elegans | 39% | 70% |
V5AZ01 | Trypanosoma cruzi | 27% | 74% |
V5B8S3 | Trypanosoma cruzi | 38% | 100% |
V5DIC3 | Trypanosoma cruzi | 32% | 95% |